History
  • No items yet
midpage
In Re Abbott Diabetes Care Inc.
696 F.3d 1142
| Fed. Cir. | 2012
Read the full case

Background

  • Abbott owns the ’752 and ’509 patents, directed to in vivo monitoring of analytes via an electrochemical sensor and a sensor control unit.
  • The Board in ex parte reexaminations rejected many claims as indefinite, anticipated, or obvious over multiple references and official notices.
  • The pivotal disputed term is “electrochemical sensor,” with the Board adopting a broad interpretation that includes sensors with external cables or wires.
  • The Board also construed “substantially fixed” in the ’509 patent to allow some movement, including movement akin to the Shichiri I system.
  • Abbott argued the Board improperly relied on the specification’s criticisms of prior art to redefine the claim term and failed to disavow sensors with cables.
  • The Federal Circuit vacates-in-part and remands for correct claim construction and remand of nineteen official-notice-based rejections.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether electrochemical sensor includes external cables Abbott contends broad construction improperly imports cables. PTO argues no explicit disclaimer required; broad reading consistent with spec. Unreasonable construction; electrochemical sensor excludes external cables.
Whether substantially fixed allows Shichiri I movement Shichiri I movement exceeds contemplated movement under substantially fixed. Some movement permissible; Board's construction allowed some movement. Movement in Shichiri I is too great; remand to apply original substantially fixed construction.
Official notice rejections nineteen official-notice rejections should be remanded/withdrawn. Board properly used official notice with prior art. Vacate remand for proper proceedings on these nineteen claims.

Key Cases Cited

  • In re American Academy of Sciences Tech Ctr., 367 F.3d 1359 (Fed. Cir. 2004) (claims should be interpreted consistent with the specification)
  • In re ICON Health & Fitness, Inc., 496 F.3d 1374 (Fed. Cir. 2007) (claims given broadest reasonable interpretation consistent with the specification)
  • Phillips v. AWH Corp., 415 F.3d 1303 (Fed. Cir. 2005) (en banc guidance on claim construction; specification as guide)
  • Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576 (Fed. Cir. 1996) (definitive guidance on claim construction and specification role)
  • Retractable Technologies, Inc. v. Becton, Dickinson & Co., 653 F.3d 1296 (Fed. Cir. 2011) (disavowal analysis in background/description contexts)
  • In re Bigio, 381 F.3d 1320 (Fed. Cir. 2004) (disavowal standards for claim scope in prosecution history)
  • Am. Acad. Sci. Tech Ctr. v. Am. Ass'n for the Advancement of Sci., 367 F.3d 1359 (Fed. Cir. 2004) (discretion in reliance on specification for claim meaning)
Read the full case

Case Details

Case Name: In Re Abbott Diabetes Care Inc.
Court Name: Court of Appeals for the Federal Circuit
Date Published: Sep 28, 2012
Citation: 696 F.3d 1142
Docket Number: 2011-1516, 2011-1517; Reexamination 90/007,903, 90/007,910
Court Abbreviation: Fed. Cir.